Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT00573378
Title Imatinib or Nilotinib With Pegylated Interferon-alpha2b in Chronic Myeloid Leukemia
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Cancer Center

chronic myeloid leukemia


Imatinib + Interferon alpha-2b

Interferon alpha-2b + Nilotinib

Age Groups: adult
Covered Countries USA

No variant requirements are available.